Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt University Medical Center
With
National Heart, Lung, and Blood Institute (NHLBI)
The objective of this study is to determine the feasibility of this approach by enrolling a pilot cohort of 16 participants in this DBRCT of 4 different albuterol treatment regimens, 2 of which will use 10mg/hr and 2 of which will use 25mg/hr. Participants are randomized in randomly permuted blocks of four. Within these dosages there will be a pulsed-treatment regimen and a continuous regimen.
Age
5–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Doctor diagnosed asthma
Acute asthma exacerbation
Treatment with systemic corticosteroids and nebulized albuterol
Ages 5 to 17 years
You may not be if
Other acute or chronic lung disease
Clareo Health | Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
